Autologous Cancer Vaccines: A Precision Immunotherapy Strategy for Veterinary Cancer Patients
Anticancer Research · 2025
DOI: 10.21873/anticanres.17766 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Anticancer Research, 2025. Verfasst von Chelsea B Greenberg und 4 weiteren Autor:innen. Beteiligte Einrichtung: Private Consultant, Salt Lake City, UT, U.S.A. Hauptthemen laut MEDLINE: Cancer Vaccines, Neoplasms, Precision Medicine, Immunotherapy. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Themen: Onkologische Pflege
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Private Consultant, Salt Lake City, UT, U.S.A.
- Torigen Pharmaceuticals, Inc., Farmington, CT, U.S.A.; msuckow@uky.edu.
- F. Joseph Halcomb III, Department of Biomedical Engineering, University of Kentucky, Lexington, KY, U.S.A.
- Torigen Pharmaceuticals, Inc., Farmington, CT, U.S.A.
- Central Texas Veterinary Specialty & Emergency Hospital, Round Rock, TX, U.S.A.
Zitieren
APA
Greenberg, C. B., Suckow, M. A., Clauson, R. M., Kalinauskas, A. E., & Lucroy, M. D. (2025). Autologous Cancer Vaccines: A Precision Immunotherapy Strategy for Veterinary Cancer Patients. Anticancer Research. https://doi.org/10.21873/anticanres.17766
Vancouver
Greenberg CB, Suckow MA, Clauson RM, Kalinauskas AE, Lucroy MD. Autologous Cancer Vaccines: A Precision Immunotherapy Strategy for Veterinary Cancer Patients. Anticancer Research. 2025. doi:10.21873/anticanres.17766
BibTeX
@article{Greenberg2025,
author = {Greenberg, Chelsea B and Suckow, Mark A and Clauson, Ryan M and Kalinauskas, Ashley E and Lucroy, Michael D},
title = {Autologous Cancer Vaccines: A Precision Immunotherapy Strategy for Veterinary Cancer Patients},
journal = {Anticancer Research},
year = {2025},
doi = {10.21873/anticanres.17766}
}
EUVIMED